Cell in Cells - Crunchbase Company Profile & Funding

Q: Who invested in Cell in Cells?

Cell in Cells has 7 investors including Korea Kolmar Co. And Korea Investment Partners.

Q: When was the last funding round for Cell in Cells?

Cell in Cells closed its last funding round on obfuscated from a Series B round.

Q: How much funding has Cell in Cells raised to date?

Cell in Cells has raised obfuscated.

Overview

Cell in Cells

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Cell in Cells

CB Rank

82498

Cell in Cells researches and develops cell therapy products for regenerative medicine through the 3D technology of stem cells.

Founded

obfuscation

Private

Series B

Seoul, Seoul-t'ukpyolsi, South Korea

11-50

www.cellincells.com

3D Technology

Biotechnology

Medical

Funding Rounds

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Details

Legal Name

CELLinCELLS co.,Ltd.

Operating Status

Active

Company Type

For Profit

About the Company

Cell in Cells is a biotechnology and life sciences company. It is involved in cell therapy and regenerative medicine. The company developed Therapeutic Organoid Intelligence, a proprietary platform to harness cells' self-organizing potential to regenerate and restructure tissues without synthetic scaffolds.

Phone Number

+82 02 740 8641

Contact Email

office@cellincells.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

TRTP-101

A 3D micro-organoid skin regeneration therapy composed of mesenchymal stem cells and extracellular matrix, used to treat atrophic scars by strengthening the body's extracellular matrix.

TRTP-20X

An organoid-based regenerative therapy targeting cartilage defects and osteoarthritis, aiming to treat the root cause of osteoarthritis.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Cell in Cells	6	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Cell in Cells	6	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Cell in Cells	6	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Cell in Cells	6	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Cell in Cells	6	obfuscated obfuscation	—	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Cell in Cells	6	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Cell in Cells	6	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Cell in Cells	6	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Cell in Cells	6	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Cell in Cells	6	obfuscated obfuscation	—	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Korea Kolmar Co.	—	Series B - Cell in Cells	—
Korea Kolmar Co.	—	Series B - Cell in Cells	—
Korea Kolmar Co.	—	Series B - Cell in Cells	—
Korea Kolmar Co.	—	Series B - Cell in Cells	—
Korea Kolmar Co.	—	Series B - Cell in Cells	—